RevCycle Intelligence January 13, 2021
The COVID-19 pandemic did not halt healthcare merger and acquisition actvitiy in 2020 and could be the catalyst for strategic transactions in the new year.
Despite delivering an economic blow to provider organizations, the pandemic confirmed the “strategic rationale” for healthcare mergers and acquisitions, according to consulting firm Kaufman Hall.
A year-end analysis of healthcare merger and acquisition activity in 2020 found that there were 79 transactions announced, significantly down from the 92 transactions announced in 2019 but marginally higher than the decade low in 2010 (74 transactions).
Additionally, seven of the transactions announced in 2020 were “mega mergers,” which the firm defines as a merger involving two companies with over $1 billion in annual revenue. There were only three...
Today's Sponsors
Today's Sponsor